However, the recently proposed role of FLVCR1a as a choline importer introduces novel perspectives and implies that, in conjunction with the regulation of ALAS1 and heme biosynthesis, FLVCR1a's involvement in both diabetes and cancer may also hinge on choline-related mechanisms. Here, ALAS1 is linked to cancer.